Abbvie Inc Stock Buy Hold or Sell Recommendation
| ABBV Stock | USD 203.99 0.09 0.04% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding AbbVie Inc is 'Buy'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell AbbVie Inc given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for AbbVie Inc, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out AbbVie Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as AbbVie and provide practical buy, sell, or hold advice based on investors' constraints. AbbVie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
AbbVie |
Execute AbbVie Buy or Sell Advice
The AbbVie recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on AbbVie Inc. Macroaxis does not own or have any residual interests in AbbVie Inc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute AbbVie's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Buy
Market Performance | Good | Details | |
Volatility | Very steady | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
AbbVie Trading Alerts and Improvement Suggestions
| AbbVie Inc currently holds 67.14 B in liabilities with Debt to Equity (D/E) ratio of 4.37, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AbbVie Inc has a current ratio of 0.91, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about AbbVie's use of debt, we should always consider it together with its cash and equity. | |
| AbbVie Inc has a strong financial position based on the latest SEC filings | |
| About 74.0% of AbbVie shares are held by institutions such as insurance companies | |
| On 14th of February 2025 AbbVie paid $ 1.64 per share dividend to its current shareholders | |
| Latest headline from benzinga.com: Heres How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years |
AbbVie Returns Distribution Density
The distribution of AbbVie's historical returns is an attempt to chart the uncertainty of AbbVie's future price movements. The chart of the probability distribution of AbbVie daily returns describes the distribution of returns around its average expected value. We use AbbVie Inc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of AbbVie returns is essential to provide solid investment advice for AbbVie.
| Mean Return | 0.35 | Value At Risk | -1.47 | Potential Upside | 3.04 | Standard Deviation | 1.38 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of AbbVie historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
AbbVie Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as AbbVie, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading AbbVie Inc back and forth among themselves.
| Shares | Northern Trust Corp | 2024-12-31 | 21.8 M | Fmr Inc | 2024-12-31 | 18.1 M | Franklin Resources Inc | 2024-12-31 | 17.2 M | Capital World Investors | 2024-12-31 | 16.4 M | Bank Of New York Mellon Corp | 2024-12-31 | 13.7 M | Ameriprise Financial Inc | 2024-12-31 | 13 M | Ubs Group Ag | 2024-12-31 | 12.6 M | Ubs Asset Mgmt Americas Inc | 2024-12-31 | 12.1 M | Legal & General Group Plc | 2024-12-31 | 11.6 M | Vanguard Group Inc | 2024-12-31 | 173.1 M | Blackrock Inc | 2024-12-31 | 142 M |
AbbVie Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (40M) | (142M) | (686M) | (417M) | (319M) | (303.1M) | |
| Change In Cash | (31.5B) | 1.3B | (545M) | 3.6B | (7.3B) | (6.9B) | |
| Free Cash Flow | 16.8B | 22.0B | 24.2B | 22.1B | 18.8B | 12.6B | |
| Depreciation | 6.5B | 8.5B | 8.5B | 8.7B | 8.4B | 8.8B | |
| Other Non Cash Items | 8.0B | 4.2B | 6.1B | 8.6B | 6.7B | 3.4B | |
| Capital Expenditures | 798M | 787M | 695M | 777M | 974M | 640.3M | |
| Net Income | 4.6B | 11.5B | 11.8B | 4.9B | 4.3B | 6.2B | |
| End Period Cash Flow | 8.4B | 9.7B | 9.2B | 12.8B | 5.5B | 9.6B | |
| Investments | 114M | (1.4B) | (447M) | (2.0B) | (20.8B) | (19.8B) | |
| Change Receivables | (74M) | (929M) | (1.3B) | (1.5B) | (1.3B) | (1.2B) | |
| Net Borrowings | 25.8B | (2.7B) | (8.4B) | (12.4B) | (11.2B) | (10.6B) | |
| Dividends Paid | 7.7B | 9.3B | 10.0B | 10.5B | 11.0B | 7.0B | |
| Change To Netincome | 4.8B | 6.4B | 4.0B | 2.6B | 3.0B | 3.4B |
AbbVie Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to AbbVie or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that AbbVie's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a AbbVie stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.34 | |
β | Beta against Dow Jones | 0.09 | |
σ | Overall volatility | 1.36 | |
Ir | Information ratio | 0.25 |
AbbVie Volatility Alert
AbbVie Inc has relatively low volatility with skewness of 0.74 and kurtosis of 1.16. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure AbbVie's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact AbbVie's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.AbbVie Fundamentals Vs Peers
Comparing AbbVie's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze AbbVie's direct or indirect competition across all of the common fundamentals between AbbVie and the related equities. This way, we can detect undervalued stocks with similar characteristics as AbbVie or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of AbbVie's fundamental indicators could also be used in its relative valuation, which is a method of valuing AbbVie by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare AbbVie to competition |
| Fundamentals | AbbVie | Peer Average |
| Return On Equity | 0.62 | -0.31 |
| Return On Asset | 0.0826 | -0.14 |
| Profit Margin | 0.08 % | (1.27) % |
| Operating Margin | 0.33 % | (5.51) % |
| Current Valuation | 421.86 B | 16.62 B |
| Shares Outstanding | 1.77 B | 571.82 M |
| Shares Owned By Insiders | 0.50 % | 10.09 % |
| Shares Owned By Institutions | 73.95 % | 39.21 % |
| Number Of Shares Shorted | 18.93 M | 4.71 M |
| Price To Earning | 21.28 X | 28.72 X |
| Price To Book | 107.29 X | 9.51 X |
| Price To Sales | 6.40 X | 11.42 X |
| Revenue | 56.33 B | 9.43 B |
| Gross Profit | 39.61 B | 27.38 B |
| EBITDA | 14.91 B | 3.9 B |
| Net Income | 4.29 B | 570.98 M |
| Cash And Equivalents | 11.88 B | 2.7 B |
| Cash Per Share | 6.72 X | 5.01 X |
| Total Debt | 67.14 B | 5.32 B |
| Debt To Equity | 4.37 % | 48.70 % |
| Current Ratio | 0.93 X | 2.16 X |
| Book Value Per Share | 1.88 X | 1.93 K |
| Cash Flow From Operations | 18.81 B | 971.22 M |
| Short Ratio | 3.11 X | 4.00 X |
| Earnings Per Share | 2.38 X | 3.12 X |
| Price To Earnings To Growth | 2.71 X | 4.89 X |
| Target Price | 204.43 | |
| Number Of Employees | 55 K | 18.84 K |
| Beta | 0.56 | -0.15 |
| Market Capitalization | 360.27 B | 19.03 B |
| Total Asset | 135.16 B | 29.47 B |
| Retained Earnings | (7.9 B) | 9.33 B |
| Working Capital | (13.17 B) | 1.48 B |
Note: Disposition of 87050 shares by Richard Gonzalez of AbbVie at 61.36 subject to Rule 16b-3 [view details]
AbbVie Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as AbbVie . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 137630.0 | |||
| Daily Balance Of Power | (0.02) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 204.18 | |||
| Day Typical Price | 204.12 | |||
| Price Action Indicator | (0.23) | |||
| Period Momentum Indicator | (0.09) | |||
| Relative Strength Index | 67.29 |
About AbbVie Buy or Sell Advice
When is the right time to buy or sell AbbVie Inc? Buying financial instruments such as AbbVie Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having AbbVie in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Alcohol Thematic Idea Now
Alcohol
Companies involved in production and distribution of wines and alcoholic beverages. The Alcohol theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Alcohol Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for AbbVie Stock Analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.